Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo.
A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo. Blood. 2002 Jun 01; 99(11):3885-91.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Apoptosis
Bone Marrow Cells
Carbazoles
Cell Survival
Enzyme Inhibitors
fms-Like Tyrosine Kinase 3
Furans
Humans
Indoles
Kinetics
Leukemia, Myeloid, Acute
Mice
Mice, Inbred BALB C
Mitogen-Activated Protein Kinase 1
Mitogen-Activated Protein Kinase 3
Mitogen-Activated Protein Kinases
Point Mutation
Proto-Oncogene Proteins
Receptor Protein-Tyrosine Kinases
Reverse Transcriptase Polymerase Chain Reaction
Transplantation, Heterologous
Tumor Cells, Cultured